AI in drug discovery newsletters
NewsletterFIT tracks 4 newsletters that cover AI in drug discovery as a primary topic, all with posts in the last 90 days. By publicly shown subscriber count, the largest are Where Tech Meets Bio (12K), Biotech Blueprint (7K) and Deep Phenotype, a Substack by insitro (2K). Brands detected sponsoring these newsletters recently include In Extenso Innovation Croissance.
Updated Oct 30, 2026 · sorted by publicly shown subscribers · methodology
- 1 Where Tech Meets Bio 12K subscribers
Substack Every two weeks · last post 7 days ago
Likely audience: Venture capitalists
Sponsors detected: In Extenso Innovation Croissance
- 2 Biotech Blueprint 7K subscribers
Substack Every two weeks · last post 14 days ago
Likely audience: Biotech investors
- 3 Deep Phenotype, a Substack by insitro 2K subscribers
Substack Monthly or less · last post Aug 28, 2026
Likely audience: Science researchers
- 4
LinkedIn Monthly or less · last post 16 days ago
Likely audience: Life sciences researchers
Latest posts from these newsletters
- 13 AI… Where Tech Meets Bio
- Merck paid… Biotech Blueprint
- Weekly Tech+Bio… Where Tech Meets Bio
- The Next… One Leap Ahead
- Vaxcyte’s pneumococcal… Biotech Blueprint
- Weekly Tech+Bio… Where Tech Meets Bio
- AstraZeneca spent… Biotech Blueprint
- Four phase… Biotech Blueprint